KATIE BOLDUC: Open Payments
NPI 1043607054 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 20 payments from 9 companies in 2025. Trend: 2023 $272 · 2024 $477 · 2025 $478
Food & beverage: $378Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $161 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| GENZYME CORPORATION | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Amgen Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $30 |
| UCB, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: TREMFYA, DUPIXENT, COSENTYX, OTEZLA, SKYRIZI, Bimzelx, NEMLUVIO, Sotyktu.
Industry payments across WV — which companies pay providers there.
